Phase i study of fixed dose gemcitabine plus epirubicin in patients with advanced solid malignancies

Daruka Mahadevan, Luke Dreisbach, Timothy Kristedja, Debbie Williams, Yrma Obregon, Sandy Kurtin, Daniel D. Von Hoff

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'Phase i study of fixed dose gemcitabine plus epirubicin in patients with advanced solid malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences